Ex Vivo Treatment By Mitapivat, an Allosteric Pyruvate Kinase Activator, Reduced Oxidative Stress and Promoted Terminal Erythropoiesis in a Severe Hemolytic Anemia Patient Due to Kr.ppel-like Factor 1 Mutations

被引:0
|
作者
Suksangpleng, Thidarat [1 ]
Tachavanich, Kalaya [2 ]
Viprakasit, Vip [2 ]
机构
[1] Mahidol Univ, Fac Med, Siriraj Thalassemia Ctr, Siriraj Hosp, Bangkok, Thailand
[2] Mahidol Univ, Fac Med, Dept Pediat, Siriraj Hosp, Bangkok, Thailand
关键词
D O I
10.1182/blood-2023-179130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 1 条
  • [1] Phenotypic Corrections of Ex Vivo Erythrocytes Derived from Chronic Hemolytic Anemia Patients Due to Kruppel-like Factor 1 (KLF-1) Mutations By AG-348: A Novel Synthetic Pyruvate Kinase Activator
    Suksangpleng, Thidarat
    Tachavanich, Kalaya
    Riolueang, Suchada
    Ekwattanakit, Supachai
    Viprakasit, Vip
    BLOOD, 2019, 134